Advent Life Sciences

ADVENT LIFE SCIENCES, A VENTURE CAPITAL FIRM FOR VISIONARY INNOVATORS

Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and investment success through turning break-through science into approved medicines or medical products.

We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery – small molecules, biologics and new modalities – med tech, enabling technologies and vaccines.

As entrepreneurs and experienced, pragmatic investors, we bring the intellectual capital of our well connected team to support each investment. We work in close alignment with our management teams, and partner with them to realise their vision – achieving superior financial returns by bringing innovation to patients.

The companies in which we have invested since the year 2006 have discovered and developed, fourteen approved medicines and products – to the benefit of patients, physicians and our investors.

Advent Life Sciences. Innovation. Clarity. Execution.

Investment Approach

The journey from innovative science to an approved medicine or product is long, difficult, complex and often fraught – we understand. We really do. Between us, our team has taken that journey many times, several of us more than once.

Our approach to investing and Company building focuses on:

  • understanding the true essence of the innovation and product concept
  • its competitive relevance in an evolving environment, and the most meaningful value-creation steps along the way
  • working in open communication with Founders and Executives, sharing our diligence and our team’s insights, to refine their business and operating plans
  • and, together, agreeing the scientific and clinical approach, the matching operating plan, team development, syndication, and financing strategy – the five key elements to building a great Biotech company

Once we are committed to a Company, a Founder or a Team, we pride ourselves on being loyal and pragmatic partners along the Company’s journey – constructively critical whilst being patient, supportive and aligned in our aims.

Advent Life Sciences. Innovation. Clarity. Execution.

Innovation Record

Since the year 2006, Advent-backed Companies have brought fourteen innovative medicines and products to approval. As the mid- and late-stage clinical pipelines of our Portfolio Companies continue to grow, this number looks set to increase each year.

Innovation Record,aDVENT lIFE sCIENCES